优化基因增强的ERA改善了反复植入失败的患者体外受精结果:元分析
Tingting Song1, Weili Zhu2, Meilin Wang3
1Department of Gynecology, Luo Yang-Dongfang Renmin Hospital, The Third Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China.
Medicine
|March 11, 2025
概括
以子宫内膜受体分析 (ERA) 为指导的个性化胚胎移植 (pET) 在重复植入失败 (RIF) 中表现出有限的成功. 然而,优化的基因增强ERA技术显著改善了临床怀孕和活产率.
科学领域:
- 生殖医学 生殖医学
- 遗传学 是一个遗传学.
- 临床试验 临床试验
背景情况:
- 重复植入失败 (RIF) 仍然是辅助生殖技术的一个重大挑战.
- 个性化胚胎移植 (pET),以子宫内膜受容性分析 (ERA) 为指导,是提出的解决方案.
- 针对RIF的ERA导向pET的临床有效性需要进一步研究.
研究的目的:
- 评估ERA引导的pET在患有RIF的患者中的临床效用.
- 评估ERA引导的pET对临床怀孕率 (CPR),植入率和活产率 (LBR) 的影响.
- 研究不同ERA技术的有效性,包括优化基因增强方法.
主要方法:
- 一项对14项涉及RIF患者接受ERA引导的pET的研究的元分析.
- 评估CPR,植入率和LBR作为主要结果.
- 基于RIF定义和ERA技术 (传统与优化基因增强) 的子组分析.
主要成果:
- 总的来说,与标准转移相比,ERA引导的pET并没有显著改善心肺复苏,植入率或LBR.
- 优化的基因增强ERA技术在CPR (RR,2.04) 和LBR (RR,2.61) 中显著改善.
结论:
- 在改善RIF患者怀孕结果方面,ERA引导的pET有效性有限.
- 优化基因增强的ERA技术有可能在RIF病例中增强CPR和LBR.
更多相关视频
08:06Author Spotlight: Evaluating the Impact of Immediate Partial Removal of Cumulus-Oocyte Complexes on Fertilization Efficiency and Embryo Quality
Published on: October 18, 2024
320
08:29Author Spotlight: Multiplex Immunohistochemistry for Understanding Immune Regulation by Uterine NK Cells in Pregnancy
Published on: October 25, 2024
1.0K
相关概念视频
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
